Richard E. Showalter

Author

Also Known As

R E Showalter, R SHOWALTER, R Showalter, R. E. SHOWALTER, R. E. Showalter, R. Showalter, R.E. Showalter, Richard E Showalter, Richard E. Showalter, Richard Showalter

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

General Atomics (United States)Agouron Institute Unisys (United States)Pfizer (United States)

About

Richard E. Showalter is an author at General Atomics (United States) specializing in medicine, drug discovery, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	1.1K
2	Biochemistry	14	16	1.3K
3	Natural Sciences	11	11	1.2K
4	Engineering	5	5	987
5	Public Health	1	1	22

Richard E. Showalter

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Crystal structures of human calcineurin and the human FKBP12–FK506–calcineurin complex Charles R. Kissinger, Hans E. Parge, Daniel R. Knighton, Nature Protein ChemistryCrystal StructureEngineeringBiochemistryNatural Sciences	1995	760
Intercellular signalling in <i>Vibrio harveyi</i>: sequence and function of genes regulating expression of luminescence Bonnie L. Bassler, Miriam Wright, Richard E. Showalter, Molecular Microbiology	1993	751
Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis Michele McTigue, John Wickersham, Chris Pinko, Structure Kinase DomainCrystal StructureAngiogenesisSignal TransductionReceptor Tyrosine Kinase	1999	200
Cloning and nucleotide sequence of luxR, a regulatory gene controlling bioluminescence in Vibrio harveyi Richard E. Showalter, Mark O. Martin, M. Silverman Journal of Bacteriology Environmental SignalingEngineeringGeneticsMolecular BiologyEscherichia Coli	1990	133
Identification of a locus controlling expression of luminescence genes in Vibrio harveyi Mark O. Martin, Richard E. Showalter, M. Silverman Journal of Bacteriology Environmental SignalingGeneticsLuxcdabe OperonMolecular GeneticsGenomics	1989	103
Two-site Interaction of Nuclear Factor of Activated T Cells with Activated Calcineurin Francisco Garcı́a-Cózar, Heidi Okamura, J. Aramburu, Journal of Biological Chemistry	1998	103
Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics Charles R. Kissinger, Paul A. Rejto, Laura A. Pelletier, Journal of Molecular Biology Crystal StructureNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryNatural Sciences	2004	97
Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors Peter S. Dragovich, John E. Barker, J. V. FRENCH, Journal of Medicinal Chemistry Medicinal ChemistryBiosynthesisDrug TargetUrea-containing Fkbp12 InhibitorsBiochemistry	1996	61
Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase Frank Ruebsam, Douglas E. Murphy, Chinh Van Tran, Bioorganic & Medicinal Chemistry Letters Hcv Ns5b PolymeraseBiochemistryTricyclic 5,6-Dihydro-1h-pyridin-2-onesMedicineAntiviral Therapy	2009	43
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation Thomas Doundoulakis, Alan X. Xiang, Ricardo Lira, Bioorganic & Medicinal Chemistry Letters Myxopyronin B AnalogsMedicineRna PolymeraseMolecular BiologyBiological Evaluation	2004	42

Page 1